$1.82
-0.05-2.67%
At close: May 8, 5:00 PM EST
$1.86
0.042.20%
After Hours: May 8, 6:24 PM EST
Gain Therapeutics Inc Earnings Estimates
GANXNASDAQ
Gain Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GANX
Gain Therapeutics (GANX) is scheduled to report Q1 earnings on May 22, 2026. Analysts estimate EPS of $-0.14 and quarterly revenue of N/A.
In the most recent quarter (Q4), Gain Therapeutics reported EPS of $-0.11, beating estimates of $-0.14 by 0.21%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Gain Therapeutics has averaged an EPS surprise of 0.10% and a revenue surprise of 1.00%.
Earnings Date
May 22
EPS Estimate
$-0.140
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Gain Therapeutics Earnings History
Analyze the earnings history of Gain Therapeutics using advanced sorting and filters.
Loading calendar...
Gain Therapeutics (GANX) Earnings Per Share
The chart below shows Gain Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Gain Therapeutics (GANX) Revenue
The chart below shows Gain Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
Gain Therapeutics (GANX) is scheduled to report earnings on May 22, 2026. The last reported earnings were for reported on March 26, 2026 for Q4.
What were the latest earnings per share (EPS) for Gain Therapeutics (NASDAQ:GANX)?
The Actual EPS was $-0.11, which beat the estimate of $-0.14.
What were Gain Therapeutics’s (NASDAQ:GANX) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
